Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review

Clinical Characteristics of Venous Thromboembolism in COVID-19 Patients Admitted to the Intensive Care Unit

Study of Plasminogen activator inhibitor-1 (PAI-1) in hospitalized COVID-19 patients

Assessment of the Natural Anticoagulants (Protein C, Protein S, and Antithrombin III) for COVID-19 Patients

Assessment of the Natural Anticoagulant Profile in Patients with COVID-19.

Outcome of Elevated Liver Enzymes in Patients with COVID-19 Infection

COVID 19 associated coagulopathy

Factors Affecting Outcome of Hospitalized Patients with COVID-19

CORRELATION BETWEEN DIFFERENT CLINICAL PRESENTATIONS OF COVID-19 POSITIVE PATIENTS PRESENTED TO ALEXANDRIA MAIN UNIVERSITY HOSPITAL AND THE OUTCOME

D-dimer levels in COVID-19 out-hospitalized patients in Egypt